Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for IQV, sign up here.
Income Statement
Revenue
$15.0bn
Gross Profit
$5.2bn
Earning before Tax
$1.5bn
Net Income
$1.4bn
Net Income Common Shareholders
$1.4bn
EPS
7.39
Balance Sheet
Cash
$1.4bn
Debt
$13.9bn
Assets
$26.7bn
Liabilities
$20.6bn
Equity
$6.1bn
Enterprise Value
$54.9bn
Cash Flow Statement
Net Cash from Operations
$2.1bn
Net Cash from Investing
$-1.6bn
Net Cash from Financing
$-0.4bn
Net Cash Flow
$160.0m
Free Cash Flow
$1.5bn
Free Cash Flow per Share
$8.16
Metrics
Price to Equity
31.09
Price to Equity (Damodaran)
31.31
Price to Book
6.91
Net Margin
0.09
Return on Equity
0.23
Return on Sales
0.14
Get immediate access to 5-years of reference grade data for IQV for free.
Sign upIQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients'' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
Company Info
Industry
Diagnostics & Research
Employees
87,000
Address
2400 Ellis Road
Durham, NC 27703
United States
Phone
919 998 2000
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.